Hakon Leffler
111 – 115 of 167
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3.
(
- Contribution to journal › Article
-
Mark
Galectin-3 Targeted Therapy with a Small Molecule Inhibitor Activates Apoptosis and Enhances Both Chemosensitivity and Radiosensitivity in Papillary Thyroid Cancer
(
- Contribution to journal › Article
-
Mark
Superantigen- and TLR-dependent activation of tonsillar B cells after receptor-mediated endocytosis.
(
- Contribution to journal › Article
- 2008
-
Mark
Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins.
(
- Contribution to journal › Article
-
Mark
Regulation of alternative macrophage activation by galectin-3
(
- Contribution to journal › Article